Aker BioMarine ASA (OSL:AKBM)

Norway flag Norway · Delayed Price · Currency is NOK
80.90
+1.20 (1.51%)
Aug 14, 2025, 4:25 PM CET
-17.62%
Market Cap 7.10B
Revenue (ttm) 2.10B
Net Income (ttm) 1.73B
Shares Out 87.70M
EPS (ttm) 19.86
PE Ratio 4.11
Forward PE 65.99
Dividend n/a
Ex-Dividend Date n/a
Volume 14,454
Average Volume 24,462
Open 77.80
Previous Close 79.70
Day's Range 77.80 - 80.90
52-Week Range 42.30 - 109.80
Beta 0.71
RSI 62.62
Earnings Date Oct 31, 2025

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ... [Read more]

Industry Packaged Foods
Founded 2006
Employees 249
Stock Exchange Oslo Børs
Ticker Symbol AKBM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Aker BioMarine ASA (FRA:1PG) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Aker BioMarine ASA (FRA:1PG) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges

4 weeks ago - GuruFocus

Q2 2025 Aker Biomarine ASA Earnings Call Transcript

Q2 2025 Aker Biomarine ASA Earnings Call Transcript

4 weeks ago - GuruFocus

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

6 months ago - GuruFocus